Malcolm T. Foster III, MD retweeted
These 8 leaders from our campus recently completed the Executive Leadership Institute, sponsored by the UT System. I appreciate their interest in learning more about leadership and I value the UT System’s commitment to leadership development. #leadershipmatters
Training completed for the Cor-Cinch clinical trial:
HFrEF 20% - 40%
Class 3 / ambulatory 4
Class 2 if hospitalized in the last year
LVEDD > 5.5 cm
MR 2+ or less (post TEER included)
Happy to see any possible candidate!
CT/FFR has improved diagnostic accuracy when evaluating chest pain patients for coronary artery disease. Outstanding correlation with IVUS/FFR in the cath lab. Will not replace SPECT or stress echo (due to limitations), but it is a fantastic tool.
88 yo with abdominal pain, hematochezia and weight loss. Risk factors of HTN, Chol. Hx of CABG. Abdom. CTA showed densely calcified plaque. C-scope confirmed colitis. Stented the SMA, resolving 60 mmHg gradient. What next?
My observation: iliac vein compression and one additional risk factor account for most proximal DVT’s. Nice result with thrombectomy and stenting.
Lightning Flash 16 for Pulmonary Embolism. First case in the great state of Tennessee. Fantastic team!
We enrolled the first patient in Tennessee into the APEX AV clinical trial. Alpha Vac 18 device for pulmonary thrombectomy.
PE’s often have acute on chronic characteristics in my experience. Large bore thrombectomy (and auto-transfusion) has been a very effective strategy. Photo credit to the tech and the new iPhone.
Restenosis after carotid surgery. EPD and stent restores the cerebral circulation. Awake (and chatty) patient. Local anesthesia.
Mediastinal mass. SVC syndrome. L7 thrombectomy. 16x140 ZV stent. Immediate resolution of head and neck venous congestion.
Malcolm T. Foster III, MD retweeted
Percutaneous Coil Embolization of Coronary Artery Fistula Complicated by Refractory VF
#JACCcasereports sciencedirect.com/science/ar…
Tricuspid valve endocarditis complicated by septic pulmonary emboli.
Debulked with Angiovac. Treated with Abx and discharged.
Months later, embolectomy of bilateral PA’s with FlowTriever.
Malcolm T. Foster III, MD retweeted
Presented at #SCAI2022 the Disrupt #PAD III Trial confirmed the consistent safety & effectiveness of #IVL followed by #DCB treatment to facilitate a durable approach for pts with heavily calcified fem-pop arteries largely w/o stenting. #LateBreaking
doi.org/10.1016/j.jscai.2022…
Malcolm T. Foster III, MD retweeted
jacc.org/doi/10.1016/j.jacca…
Case series of Percutaneous Aspiration and Debridment of MV #endocarditis
#JACCCaseReports @JACCJournals @JGrapsa @nbarry4 @MalcolmFoster3
Celebrating with Smokey: the Tombras School of Advertising & Public Relations @ the University of Tennessee. Great job Beth Foster! @ Circle Park instagram.com/p/CbjJggPM-Ap/…
Go VOLS! Tennessee finished the regular season undefeated at home. Great win today over the Razorbacks. SEC tourney is next week!


















